Table 1.

Distribution (number of subjects) of GM phenotypes in relation to levels (titer) of IgG antibodies to HER-2 in patients with breast cancer

GM Phenotypes	Number of Subjects	Antibody titer Median (IQR)
1,17 13,21	1	6400 (6400–6400)
1,17 21	4	300 (150–400)
1,2,17 21	5	400 (400–800)
1,2,3,17 23 5,13,21	11	1600 (400–1600)
1,2,3,17 5,13,21	8	1200 (400–1600)
1,2,3,17 21	1	400 (400–400)
1,2,3 23 5,13,21	1	400 (400–400)
1,3,17 23 5,13,21	15	800 (200–1600)
1,3,17 5,13,21	17	800 (400–1600)
3 23 5,13	77	800 (400–1600)
3 23 5,13,21	1	1600 (1600–1600)
3 5,13	11	800 (200–1600)
Total	152	800 (400–1600)

IQR: Interquartile range